BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 10577959)

  • 1. Recurrent lung shadowing in adult juvenile idiopathic arthritis.
    Lian T; Brittenden J; Pearson S; Emery P
    Ann Rheum Dis; 1999 Dec; 58(12):742-4. PubMed ID: 10577959
    [No Abstract]   [Full Text] [Related]  

  • 2. Sulfasalazine-induced angioimmunoblastic lymphadenopathy developing in a patient with juvenile chronic arthritis.
    Pay S; Dinc A; Simsek I; Can C; Erdem H
    Rheumatol Int; 2000 Dec; 20(1):25-7. PubMed ID: 11149657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of severe pulmonary infiltration with eosinophilia (PIE) syndrome induced by sulphasalazine.
    Haroon M; Harney S
    Int J Rheum Dis; 2012 Dec; 15(6):e150-2. PubMed ID: 23253243
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pulmonary eosinophilia with excavated opacities possibly induced by salazosulfapyridine].
    Khaleq K; Trombati N; Aichane A; Bahlaoui A; Bouayad Z
    Rev Mal Respir; 2001 Dec; 18(6 Pt 1):667-8. PubMed ID: 11924192
    [No Abstract]   [Full Text] [Related]  

  • 5. Sulphasalazine-induced eosinophilic pneumonia.
    Timmer R; Duurkens VA; van Hees PA
    Neth J Med; 1992 Oct; 41(3-4):153-7. PubMed ID: 1361663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulphasalazine desensitization in a paediatric patient with juvenile chronic arthritis.
    Kümmerle-Deschner J; Dannecker G
    Acta Paediatr; 1995 Aug; 84(8):952-4. PubMed ID: 7488828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salazopyrin-induced eosinophilic pneumonia.
    Cazzadori A; Braggio P; Bontempini L
    Respiration; 1985; 47(2):158-60. PubMed ID: 2860710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of three treatment strategies in recent onset non-systemic Juvenile Idiopathic Arthritis: initial 3-months results of the BeSt for Kids-study.
    Hissink Muller PC; Brinkman DM; Schonenberg D; Koopman-Keemink Y; Brederije IC; Bekkering WP; Kuijpers TW; van Rossum MA; van Suijlekom-Smit LW; van den Berg JM; Allaart CF; Ten Cate R
    Pediatr Rheumatol Online J; 2017 Feb; 15(1):11. PubMed ID: 28166785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combining cyclosporine with prevailing antirheumatic drug therapy in the treatment of juvenile idiopathic arthritis.
    Haapasaari J; Kautiainen H; Hakala M
    Clin Exp Rheumatol; 2002; 20(2):259. PubMed ID: 12051414
    [No Abstract]   [Full Text] [Related]  

  • 10. Low dose methotrexate osteopathy in a patient with polyarticular juvenile idiopathic arthritis.
    Quinn MA; Green MJ; Gough AK
    Ann Rheum Dis; 2003 Nov; 62(11):1123-4; author reply 1124. PubMed ID: 14583584
    [No Abstract]   [Full Text] [Related]  

  • 11. Successful treatment with tocilizumab of a psoriasiform skin lesion induced by etanercept in a patient with juvenile idiopathic arthritis.
    Shimizu M; Hamaguchi Y; Ishikawa S; Ueno K; Yachie A
    Mod Rheumatol; 2015; 25(6):972-3. PubMed ID: 25496406
    [No Abstract]   [Full Text] [Related]  

  • 12. Low dose methotrexate osteopathy in a patient with polyarticular juvenile idiopathic arthritis.
    Rudler M; Pouchot J; Paycha F; Gentelle S; Grasland A; Vinceneux P
    Ann Rheum Dis; 2003 Jun; 62(6):588-9. PubMed ID: 12759303
    [No Abstract]   [Full Text] [Related]  

  • 13. Sulphasalazine. An alternative drug for second-line treatment of juvenile chronic arthritis.
    Varbanova BB; Dyankov ED
    Adv Exp Med Biol; 1999; 455():331-6. PubMed ID: 10599365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sulfasalazine therapy for juvenile rheumatoid arthritis.
    Chen CC; Lin YT; Yang YH; Chiang BL
    J Formos Med Assoc; 2002 Feb; 101(2):110-6. PubMed ID: 12099201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyarticular juvenile idiopathic arthritis treated with methotrexate complicated by the development of non-Hodgkin's lymphoma.
    Cleary AG; McDowell H; Sills JA
    Arch Dis Child; 2002 Jan; 86(1):47-9. PubMed ID: 11806884
    [No Abstract]   [Full Text] [Related]  

  • 16. Tumor necrosis factor inhibitors and cancer in juvenile idiopathic arthritis: disentangling the web.
    Onel KB; Onel K
    Arthritis Rheum; 2012 Apr; 64(4):966-9. PubMed ID: 22327954
    [No Abstract]   [Full Text] [Related]  

  • 17. Pulmonary infiltrates and eosinophilia associated with sulfasalazine.
    Wang KK; Bowyer BA; Fleming CR; Schroeder KW
    Mayo Clin Proc; 1984 May; 59(5):343-6. PubMed ID: 6144819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapy-related membranous nephropathy in juvenile idiopathic arthritis with Turner syndrome.
    Suzuki K; Tanaka H; Ito E; Waga S
    Pediatr Int; 2004 Jun; 46(3):377-9. PubMed ID: 15151564
    [No Abstract]   [Full Text] [Related]  

  • 19. Bronchiolitis obliterans organizing pneumonia associated with sulfasalazine in a patient with rheumatoid arthritis.
    Ulubaş B; Sahin G; Ozer C; Aydin O; Ozgür E; Apaydin D
    Clin Rheumatol; 2004 Jun; 23(3):249-51. PubMed ID: 15168156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disease flare after 7 year-remission of systemic type juvenile idiopathic arthritis: is growth hormone therapy a culprit or innocent bystander?
    Kim JY; Kim HS; Park SH
    Int J Rheum Dis; 2015 Mar; 18(3):377-8. PubMed ID: 24785656
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.